Rothschild Investment LLC’s Aurinia Pharmaceuticals AUPH Stock Holding History

Rothschild Investment LLC’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.5K	Buy	734 +9	+1%	+$144	﹤0.01%	1763
2026 Q1	$10.7K	Buy	725 +426	+142%	+$6.23K	﹤0.01%	1655
2025 Q4	$4.77K	Buy	299 +74	+33%	+$1.05K	﹤0.01%	1911
2025 Q3	$2.49K	Sell	225 -30	-12%	-$328	﹤0.01%	2092
2025 Q2	$2.16K	Buy	255 +20	+9%	+$160	﹤0.01%	2027
2025 Q1	$1.89K	Buy	235 +45	+24%	+$365	﹤0.01%	1934
2024 Q4	$1.71K	Buy	190 +15	+9%	+$122	﹤0.01%	1903
2024 Q3	$1.28K	Buy	175 +100	+133%	+$620	﹤0.01%	1980
2024 Q2	$428	Buy	+75	New	+$395	﹤0.01%	2115
2021 Q3	–	Sell	-22,310	Closed	-$289K	–	486
2021 Q2	$289K	Hold	22,310	–	–	0.02%	400
2021 Q1	$290K	Buy	+22,310	New	+$324K	0.03%	390

Other funds holding AUPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rothschild Investment LLC's AUPH Position: Q2 2026 in Review

Rothschild Investment LLC increased its Aurinia Pharmaceuticals (AUPH) stake by 1.2% in Q2 2026, buying an estimated $144 and bringing the position to 734 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

Rothschild Investment LLC first reported a position in AUPH in Q1 2021 and has held it in 11 quarters since. The position peaked at $290K in Q1 2021. 263 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Rothschild Investment LLC held 734 shares of Aurinia Pharmaceuticals worth $12.5K as of Q2 2026.
Rothschild Investment LLC bought 9 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $144.
Aurinia Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1763 holding.
Rothschild Investment LLC first reported a position in Aurinia Pharmaceuticals in Q1 2021 and has held it in 11 quarters since.
Rothschild Investment LLC's Aurinia Pharmaceuticals position peaked at $290K in Q1 2021.
263 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.